赛诺菲对亚托皮性皮肤炎的第3期amilitelimab结果进行了介绍. Sanofi presents phase 3 amlitelimab results for atopic dermatitis.

在美国皮肤病学会年会上,赛诺菲公司介绍了对阿米莱利马布治疗亚托匹性皮炎的第三期研究新结果. Sanofi presented new results from phase 3 studies on amlitelimab for atopic dermatitis at the American Academy of Dermatology Annual Meeting. 这些数据支持该公司对治疗的积极结果的报告. The data supports the company's report of positive outcomes for the treatment.